The Janssen Pharmaceutical Companies of Johnson & Johnson
Senior Business Manager, Biotherapeutics Development
Janssen R&D
Business Support Manager
Howard Hughes Medical Institute Aug 1995 - Apr 1999
Lab Technician
Education:
Drexel University 2018
Masters, Management
Penn State University 1990 - 1995
Bachelors, Bachelor of Science, Biology
Emmaus High School
Pennsylvania State University
Skills:
Managing Partnerships With Cros Managing Physical and Virtual Inventories Encouraging Lean Thinking To Improve Upon Processes Generation and Analysis of Kpis To Drive Continuous Improvement Managing Database Data Integrity Outstanding Interpersonal Communication Skills Leveraging Work of Team Memebers To Meet Project Checkpoints Managing Complexity and Multiple Projects at Once In A Matrix Environment Dna Electrophoresis Rna Electrophoresis Protein Electrophoresis Dna Sequencing De Novo Cloning Design and Engineering of Antibody and Non Antibody Proteins Rna Extraction Rt Pcr 5' and 3' Race Elisa Cell Based Assays Immunoprecipitation Western Blotting Northern Blotting Southern Blot Immunohistochemistry Protein Expression Glp Cell Culture Protein Purification Microsoft Office Sharepoint Symyx Vector Nti Clinical Development Lifesciences Drug Discovery Pharmaceutical Industry Assay Development Biotechnology Protein Chemistry Life Sciences Cell Culture Molecular Biology Drug Development Cell Biology Immunology
Alfred Delvecchio - West Chester PA, US Ping Tsui - Berwyn PA, US Patrick Branigan - Lansdowne PA, US Leslee Conrad - Norristown PA, US Nicole Day - West Norriton PA, US Changbao Liu - Malvern PA, US Raymond Sweet - Bryn Mawr PA, US Sheng-Jiun Wu - Broomall PA, US Jose Melero - Madrid, ES Jinquan Luo - Malvern PA, US Gabriela Canziani - Blue Bell PA, US Mark Tornetta - Collegeville PA, US Gopalan Raghunathan - San Diego CA, US Venkata Koka - San Diego CA, US
International Classification:
A61K 39/12 C12Q 1/68
US Classification:
424186100, 424204100, 435006000
Abstract:
Anti-Respiratory Syncytial Virus (RSV) monoclonal antibodies, RSV F protein antigens and their uses are disclosed.
Cynomolgus Il-13 Mutein Proteins, Antibodies, Compositions, Methods And Uses
The present invention relates to at least one novel cynomolgus IL-13 muteins (Mut-IL-13) proteins, antibodies, including isolated nucleic acids that encode at least one Mut-IL-13 protein or antibody, Mut-IL-13 vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Anti-Respiratory Syncytial Virus Antibodies, Antigens And Uses Thereof
Alfred Delvecchio - West Chester PA, US Ping Tsui - Berwyn PA, US Patrick Branigan - Lansdowne PA, US Leslee Conrad - Norristown PA, US Nicole Day - West Norriton PA, US Changbao Liu - Malvern PA, US Raymond Sweet - Bryn Mawr PA, US Sheng-Jiun Wu - Broomall PA, US Jose Melero - Madrid, ES Jinquan Luo - Malvern PA, US Gabriela Canziani - Blue Bell PA, US Mark Tornetta - Collegeville PA, US Gopalan Raghunathan - San Diego CA, US Venkata Chalapathi Koka - San Diego CA, US